Brian Tomlinson

ABCG2 Polymorphism Is Associated With the Low‐Density Lipoprotein Cholesterol Response to Rosuvastatin

B. Tomlinson, L. Baum, V. Lee, 2010, Clinical pharmacology and therapeutics.